Center for Scientific Review; Notice of Closed Meetings, 15707-15708 [07-1615]

Download as PDF Federal Register / Vol. 72, No. 62 / Monday, April 2, 2007 / Notices Dated: March 26, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1611 Filed 3–20–07; 8:45 am] DEPARTMENT OF HEATLH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Closed Meeting BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. hsrobinson on PROD1PC76 with NOTICES Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; High-Accuracy Protein Structure Meeting. Date: April 20, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: C Craig Hyde, PhD, Scientific Review Administrator, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN18, MSC 6200, Bethesda, MD 20892, (301) 435– 3825, hydec@nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: March 26, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1613 Filed 3–30–07; 8:45 am] BILLING CODE 4140–01–M VerDate Aug<31>2005 18:39 Mar 30, 2007 Jkt 211001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Innovative Therapies and Clinical Studies For Screenable Disorders. Date: April 27, 2007. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Washington National Airport, 1489 Jefferson Davis Hwy., Arlington, VA 22202. Contact Person: Norman Chang, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 496–1486, changn@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: March 26, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1614 Filed 3–30–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 15707 is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Melanoma Application. Date: April 9, 2007. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Mary Bell, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6188, MSC 7804, Bethesda, MD 20892, 301–451–8754, bellmar@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Neuropharmacology and Drug Discovery. Date: April 10, 2007. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Boris P. Sokolov, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 20892, 301–435– 1197, bsokolov@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Immunology Integrated Review Group, Cellular and Molecular Immunology—B Study Section. Date: May 31–June 1, 2007. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Betty Hayden, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4206, MSC 7812, Bethesda, MD 20892, 301–435– 1223, haydenb@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, E:\FR\FM\02APN1.SGM 02APN1 15708 Federal Register / Vol. 72, No. 62 / Monday, April 2, 2007 / Notices 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 26, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1615 Filed 3–30–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Statement of Organization, Functions, and Delegations of Authority Part M of the Substance Abuse and Mental Health Services Administration (SAMHSA) Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services at 71, Number 137, FR 40730–40731, July 18, 2006 is amended to reflect the new functional statements for the Center for Substance Abuse Treatment (CSAT), Division of Services Improvement (DSI), and the Division of State and Community Assistance (DSCA). The restructuring of DSI will ensure that all activities are consolidated within a structure reflective of current Agency priorities, such as health service systems development, program quality improvement, and targeted priority populations. The DSCA role and responsibility will be clarified and made much more relevant to today’s performance management environment. This realignment of functions will have a positive impact on organizational effectiveness. The changes are as follows: Section M.20, Functions is amended as follows: The functional statements for the Center for Substance Abuse Treatment (MT), Division of Services Improvement (MTB), and the Division of State and Community Assistance (MTE) are replaced with the following: hsrobinson on PROD1PC76 with NOTICES Center for Substance Abuse Treatment (MT) Division of Services Improvement (MTB) (1) Develops, plans, implements, and monitors a national treatment capacity expansion and knowledge adoption program designed to improve treatment services for targeted populations served by both the specialty drug treatment system and other systems of care; (2) provides leadership and guidance to CSAT on strategies to improve the quality of drug treatment services delivered nationwide; (3) supports the VerDate Aug<31>2005 18:39 Mar 30, 2007 Jkt 211001 development and testing of substance abuse performance measures for public and private health plans; (4) collects, analyzes, and disseminates data and information pertaining to public and private financing and expenditures for treatment services; (5) assesses and responds to the identified needs for workforce development among substance abuse treatment and recovery support providers; (6) collaborates on the development of requests for applications and requests for contracts for the national treatment capacity expansion, knowledge adoption, quality and services improvement agenda; (7) monitors grants, cooperative agreements, contracts, interagency agreements, and memoranda of understanding for treatment capacity expansion, knowledge adoption, and quality and services improvement; (8) identifies the need for, develops, and provides technical assistance to grantees, other service providers and systems of care, and others on adoption of evidence-based practices to promote quality and services improvement, capacity expansion, and organization and financing of services; (9) establishes and maintains collaborative relationships with other Federal, State, and local governmental agencies, national organizations, and constituency groups; (10) maintains internal expertise and collaborates with national experts on the science-to-services agenda; and (11) develops funding levels for Division programs and activities. Division of State and Community Systems Development (MTE) (1) Administers the Substance Abuse Block Grant Program, including oversight and approval of Block Grant applications and maintenance of effort (MOE) issues; (2) administers the Substance Abuse Treatment National Outcome Measures (NOMs), negotiating quality improvement agreements with States; (3) monitors and ensures State compliance with legislative and regulatory provisions which apply to SAPTBG funds at State and provider levels; (4) provides guidance and technical assistance to States in preparation of State substance abuse plans; (5) conducts performance reviews of State agencies and treatment programs; (6) works closely with data and evaluation to assure proper reporting and data integrity; (7) administers the State Incentive Grant program for co-occurring disorders and the Targeted Capacity Expansion (TCE) grant program for co-occurring disorders and homelessness; (8) works collaboratively with the Division of Services Improvement on performance PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 measurement, GPRA, and HIPAA issues; and (9) serves as focus for State and local performance data analysis and development issues. Delegations of Authority All delegations and redelegations of authority to officers and employees of SAMHSA which were in effect immediately prior to the effective date of this reorganization shall continue to be in effect pending further redelegations, providing they are consistent with the reorganization. These organizational changes are effective: Dated: March 22, 2007. Terry L. Cline, Administrator. [FR Doc. E7–6014 Filed 3–30–07; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency Agency Information Collection Activities: Submission for OMB Review; Comment Request Federal Emergency Management Agency, DHS. ACTION: Notice and request for comments. AGENCY: SUMMARY: The Federal Emergency Management Agency (FEMA) has submitted the following information collection to the Office of Management and Budget (OMB) for review and clearance in accordance with the requirements of the Paperwork Reduction Act of 1995. The submission describes the nature of the information collection, the categories of respondents, the estimated burden (i.e., the time, effort and resources used by respondents to respond) and cost, and includes the actual data collection instruments FEMA will use. Title: National Fire Academy End of Course Evaluation Form. OMB Number: 1660–0032. Abstract: The National Fire Academy (NFA) is mandated under the Fire Prevention and Control Act of 1974 (Pub. L. 93–498) to provide training and education to the Nation’s fire service and emergency service personnel. The NFA End of Course Evaluation Form is used to evaluate all traditional classroom based course deliveries. The data provided by students evaluating NFA courses are used to determine the need for course improvements and the degree of student satisfaction with the training experience. All on-campus E:\FR\FM\02APN1.SGM 02APN1

Agencies

[Federal Register Volume 72, Number 62 (Monday, April 2, 2007)]
[Notices]
[Pages 15707-15708]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1615]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Melanoma Application.
    Date: April 9, 2007.
    Time: 1 p.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Mary Bell, PhD, Scientific Review Administrator, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6188, MSC 7804, Bethesda, MD 20892, 301-451-
8754, bellmar@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Neuropharmacology and Drug Discovery.
    Date: April 10, 2007.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Boris P. Sokolov, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 
20892, 301-435-1197, bsokolov@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Name of Committee: Immunology Integrated Review Group, Cellular 
and Molecular Immunology--B Study Section.
    Date: May 31-June 1, 2007.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Betty Hayden, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4206, MSC 7812, Bethesda, MD 
20892, 301-435-1223, haydenb@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844,

[[Page 15708]]

93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

    Dated: March 26, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1615 Filed 3-30-07; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.